Elsevier expands its Legacy Collection of classic historical scholarly book content on ScienceDirect, now includes more than 9,500 books from over 100 Novel Laureates

Kendall Sinclair

Kendall Sinclair

WALTHAM, Massachusetts , October 16, 2013 (press release) – Classic scholarly book titles digitized and added across 15 subject areas, including contributions from over 100 Nobel Laureates

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the expansion of its Legacy Collection on ScienceDirect. Elsevier’s Legacy Collection now includes more than 9500 books with contributions from more than 100 Nobel Laureates.

The Legacy Collection digitizes classic historical scholarly book content. Many of these newly digitized foundational books were difficult to find in print or out-of-print altogether. Having this content secured and fully integrated on ScienceDirect enables digital searching and deep reference linking on this historical reference material, completing library collections and expanding holdings without the burden of locating or borrowing.

The expanded content now covers 15 subject areas, including:

Agricultural and biological sciences
Biochemistry, genetics and molecular biology
Biomedical science and medicine
Chemical engineering
Chemistry
Earth and planetary sciences
Energy
Engineering
Environmental science
Materials science
Neuroscience
Pharmacology, toxicology and pharmaceutical science
Physics and astronomy
Psychology
Social sciences

“Some might wonder why researchers would be interested in historical content, some of which dates back to the 1950s,” said Suzanne BeDell, Managing Director of Elsevier’s Science and Technology Books. “Much of the content in our Legacy Collection provides the foundation for science as we know it and researchers often refer back to important, original texts to get a better understanding of the research they are doing today.”

Elsevier’s Legacy Collection is available on ScienceDirect, a full-text scientific database offering journal articles and book chapters from more than 2,500 peer-reviewed journals and more than 11,000 books.

About ScienceDirect

ScienceDirect is home to almost one-quarter of the world's peer-reviewed full-text scientific, technical and medical content. Over 15 million researchers, health care professionals, teachers, students and information professionals around the globe rely on ScienceDirect as a trusted source of nearly 2,200 journals, almost 900 serials and close to 22,000 book titles. ScienceDirect supports research and education with interactive elements in articles such as audio, video, graphs, tables and images, and offers tools so users can easily set alerts. Content on ScienceDirect also features embedded links to external datasets, including earth and environmental science data from PANGAEA, abstract and indexing data from Scopus and chemical reactions data from Reaxys. With almost 12 million content pieces available—including pre-publication release of articles and open access content from Elsevier journals—ScienceDirect is a premier platform for discovering the world of research.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

BW-image© 2024 Business Wire, Inc., All rights reserved.

Share:

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.